The Costa Rican Social Security System (CCSS) will temporarily suspend the use of hydroxychloroquine and lopinavir-ritonavir as treatments for COVID-19 patients.
Costa Rican health authorities said Monday that the country will reevaluate its strategy of using hydroxychloroquine to treat coronavirus patients after the World Health Organization (WHO) suspended clinical trials of the drug.
A Swiss pharmaceutical company has donated a substantial amount of hydroxychloroquine that will be used to treat patients hospitalized with COVID-19 in Costa Rica.